These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 18157530

  • 21. Safety and antitumor efficacy of (153)Sm-EDTMP and docetaxel administered sequentially to patients with metastatic castration-resistant prostate cancer.
    Borsò E, Boni G, Pastina I, Lorenzoni A, Cianci C, Federici F, Mazzarri S, Orlandini C, Francesca F, Selli C, Ricci S, Rubello D, Mariani G.
    Nucl Med Commun; 2014 Jan; 35(1):88-94. PubMed ID: 24157942
    [Abstract] [Full Text] [Related]

  • 22. Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
    Scher HI, Curley T, Yeh S, Tong W, O'Moore PV, Larson S.
    Adv Exp Med Biol; 1992 Jan; 324():115-29. PubMed ID: 1283494
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P, Nuñez R.
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
    [Abstract] [Full Text] [Related]

  • 25. Optimal treatment of painful bone metastases with Samarium EDTMP in a haemodialysis patient: effectiveness and safety of internal radiotherapy.
    Skalli S, Desruet MD, Bourre JC, Caravel JP, Vuillez JP.
    Nephrol Dial Transplant; 2009 Aug; 24(8):2598-600. PubMed ID: 19369693
    [Abstract] [Full Text] [Related]

  • 26. Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial.
    Heery CR, Madan RA, Stein MN, Stadler WM, Di Paola RS, Rauckhorst M, Steinberg SM, Marté JL, Chen CC, Grenga I, Donahue RN, Jochems C, Dahut WL, Schlom J, Gulley JL.
    Oncotarget; 2016 Oct 18; 7(42):69014-69023. PubMed ID: 27486817
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Myelotoxicity after systemic radionuclide therapy of painful bone metastases with 153Samarium-EDTMP ].
    Dolezal J, Vizd'a J, Cermáková E.
    Vnitr Lek; 2003 Mar 18; 49(3):189-93. PubMed ID: 12728593
    [Abstract] [Full Text] [Related]

  • 30. [Primary investigation of dose-effect relationship of 153Sm-EDTMP in treating multiple bone metastases].
    Fan W, Chen LX, Liu XW, Tang Q, Wang GH, Zhi SF, Zeng ZY.
    Ai Zheng; 2006 Nov 18; 25(11):1395-8. PubMed ID: 17094908
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Samarium-153 therapy for prostate cancer: the evaluation of urine activity, staff exposure and dose rate from patients.
    Parlak Y, Gumuser G, Sayit E.
    Radiat Prot Dosimetry; 2015 Mar 18; 163(4):468-72. PubMed ID: 25063786
    [Abstract] [Full Text] [Related]

  • 35. Improving the dose-myelotoxicity correlation in radiometabolic therapy of bone metastases with 153Sm-EDTMP.
    Pacilio M, Ventroni G, Basile C, Ialongo P, Becci D, Mango L.
    Eur J Nucl Med Mol Imaging; 2014 Feb 18; 41(2):238-52. PubMed ID: 24077786
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A, Braga FJ, Graeff CF, Baffa O.
    Appl Radiat Isot; 2001 Feb 18; 54(2):269-74. PubMed ID: 11200888
    [Abstract] [Full Text] [Related]

  • 39. Prospective 153Sm-EDTMP therapy dosimetry by whole-body scintigraphy.
    Cameron PJ, Klemp PF, Martindale AA, Turner JH.
    Nucl Med Commun; 1999 Jul 18; 20(7):609-15. PubMed ID: 10423762
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.